Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Annual Review of Medicine
|
January 12, 2010
Emotion recollected in tranquility: lessons learned from the COX-2 saga
Tilo Grosser, Ying Yu, Garret A Fitzgerald
Trends in Pharmacological Sciences
|
June 28, 2017
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser, Emanuela Ricciotti, Garret A FitzGerald
Circulation Research
|
February 17, 2018
Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment
Tilo Grosser, Ali Naji, Garret A FitzGerald
Platelets
|
January 20, 2017
Microfluidic whole blood testing of platelet response to pharmacological agents
Ruizhi Li, Tilo Grosser, Scott L Diamond
Science (New York, N.Y.)
|
September 5, 2020
Reopening schools during COVID-19
Ronan Lordan, Garret A FitzGerald, Tilo Grosser
Clinical Pharmacology and Therapeutics
|
July 16, 2017
Cyclooxygenase Inhibition: Pain, Inflammation, and the Cardiovascular System
Tilo Grosser, Katherine N Theken, Garret A FitzGerald
Hypertension (Dallas, Tex. : 1979)
|
July 21, 2022
Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
J David Spence, Tilo Grosser, Garret A FitzGerald
Science (New York, N.Y.)
|
March 11, 2017
Time for nonaddictive relief of pain
Tilo Grosser, Clifford J Woolf, Garret A FitzGerald
Proceedings of the National Academy of Sciences of the United States of America
|
January 8, 2013
COX-2, the dominant source of prostacyclin
Emanuela Ricciotti, Ying Yu, Tilo Grosser, et al.
Child Development
|
March 25, 2010
Fetal genotype for the xenobiotic metabolizing enzyme NQO1 influences intrauterine growth among infants whose mothers smoked during pregnancy
Thomas S Price, Tilo Grosser, Robert Plomin, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Annual Review of Medicine
|
January 12, 2010
Emotion recollected in tranquility: lessons learned from the COX-2 saga
Tilo Grosser, Ying Yu, Garret A Fitzgerald
Trends in Pharmacological Sciences
|
June 28, 2017
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser, Emanuela Ricciotti, Garret A FitzGerald
Circulation Research
|
February 17, 2018
Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment
Tilo Grosser, Ali Naji, Garret A FitzGerald
Platelets
|
January 20, 2017
Microfluidic whole blood testing of platelet response to pharmacological agents
Ruizhi Li, Tilo Grosser, Scott L Diamond
Science (New York, N.Y.)
|
September 5, 2020
Reopening schools during COVID-19
Ronan Lordan, Garret A FitzGerald, Tilo Grosser
Clinical Pharmacology and Therapeutics
|
July 16, 2017
Cyclooxygenase Inhibition: Pain, Inflammation, and the Cardiovascular System
Tilo Grosser, Katherine N Theken, Garret A FitzGerald
Hypertension (Dallas, Tex. : 1979)
|
July 21, 2022
Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
J David Spence, Tilo Grosser, Garret A FitzGerald
Science (New York, N.Y.)
|
March 11, 2017
Time for nonaddictive relief of pain
Tilo Grosser, Clifford J Woolf, Garret A FitzGerald
Proceedings of the National Academy of Sciences of the United States of America
|
January 8, 2013
COX-2, the dominant source of prostacyclin
Emanuela Ricciotti, Ying Yu, Tilo Grosser, et al.
Child Development
|
March 25, 2010
Fetal genotype for the xenobiotic metabolizing enzyme NQO1 influences intrauterine growth among infants whose mothers smoked during pregnancy
Thomas S Price, Tilo Grosser, Robert Plomin, et al.
Page
of 8